OHSU Knight Cancer Institute: all 243 studies

Page 1 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck CancersRecruitingNCT07857655Phase 4
• Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet DisorderRecruitingNCT07844694Phase 1
• Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER TrialRecruitingNCT07726602
• Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer TrialNot yet recruitingNCT07664241Not applicable
• Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint InhibitorNot yet recruitingNCT07660666Not applicable
• A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant ChemotherapyRecruitingNCT07651358Not applicable
• Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES TrialNot yet recruitingNCT07606313Not applicable
• Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationRecruitingNCT07548983Phase 1
• Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular CarcinomaNot yet recruitingNCT07511504Phase 2
• GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate CancerRecruitingNCT07504835Not applicable
• Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRTRecruitingNCT07498517Phase 2
• Mammogram Pretreatment With Ulipristal AcetateRecruitingNCT07434128Phase 2
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
• An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO TrialRecruitingNCT07278440Not applicable
• Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaRecruitingNCT07228273Phase 2
• OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07089940Early Phase 1
• Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity SyndromeRecruitingNCT06895473Phase 2
• Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentRecruitingNCT06784167
• Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With CancerRecruitingNCT06562777
• Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLRecruitingNCT06504459Phase 2
• Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL TrialRecruitingNCT06357676Phase 1/2
• Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT06357182Phase 1
• CREATE: Art for Children With CancerRecruitingNCT06342453Not applicable
• Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06320405Phase 1/2
• Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell LymphomaRecruitingNCT06249191Phase 1/2
• Use Of Indocyanine Green In Pancreas SurgeryRecruitingNCT06084013
• Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal CancerRecruitingNCT06067438Phase 2
• EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
• Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVERecruitingNCT06011499Not applicable
• Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaRecruitingNCT05943496Phase 1
• Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal TherapyRecruitingNCT05919329Phase 4
• Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
• Impact of Dietary Fiber Supplementation on Colonic MicrobiomeRecruitingNCT05643859Not applicable
• A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic TumorsNot yet recruitingNCT05453851Phase 1/2
• Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerRecruitingNCT05081024
• MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and ReferralsEnrolling by invitationNCT04996316
• Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT04659616Phase 1
• 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerRecruitingNCT04529044Phase 2
• Identifying and Caring for Individuals With Inherited Cancer SyndromeRecruitingNCT04494945Not applicable
• Targeted Pathway Inhibition in Patients With Pancreatic CancerRecruitingNCT04005690Early Phase 1
• Feasibility of FMISO in Brain TumorsRecruitingNCT03649880Phase 2
• Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other DisordersAvailableNCT03626285
• Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingNCT03270059Phase 2
• Pathogenesis of Hematologic MalignanciesEnrolling by invitationNCT01728402
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerTerminatedNCT06630325Phase 2Results posted
• Enhancing Skin Cancer Early Detection and Treatment in Primary CareCompletedNCT05675709Not applicableResults posted
• At-Home Dermoscopy Artificial IntelligenceTerminatedNCT05321784Not applicableResults posted
• Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking CessationCompletedNCT04969978Not applicableResults posted
• Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal PancreatectomyTerminatedNCT04965311Phase 2Results posted
• Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRCCompletedNCT04890054Not applicableResults posted
• NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic CancerActive, not recruitingNCT04539808Phase 2Results posted
• Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving ChemotherapyTerminatedNCT04465760Phase 2Results posted
• mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic CholangiocarcinomaTerminatedNCT04251715Phase 2Results posted
• Progressive Resistance Training for the Improvement of Physical FunctionCompletedNCT04247425Not applicableResults posted
• Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerTerminatedNCT03995667Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Liver CancerTerminatedNCT03812289Not applicableResults posted
• GET FIT Prostate: A Randomized Controlled Exercise TrialCompletedNCT03741335Not applicableResults posted
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT03557970Phase 2Results posted
• Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With GlioblastomaTerminatedNCT03347617Phase 2Results posted
• Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesTerminatedNCT03325166Phase 2Results posted
• Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell TransplantCompletedNCT03097588Phase 2Results posted
• Obinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell LymphomaCompletedNCT02736617Phase 2Results posted
• Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT02522715Phase 1/2Results posted
• Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate CancerTerminatedNCT02501759Not applicableResults posted
• Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02427841Phase 2Results posted
• Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideActive, not recruitingNCT02312557Phase 2Results posted
• Esophageal Cytology With FISH in Detecting Esophageal CancerCompletedNCT02100189Not applicableResults posted
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide TherapyCompletedNCT02099864Phase 2Results posted
• Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid LeukemiaCompletedNCT02092324Phase 2Results posted
• Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue SarcomaCompletedNCT02050919Phase 2Results posted
• Abraxane/BevacizumabTerminatedNCT01821859Phase 2Results posted
• Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal CancerCompletedNCT01748942Not applicableResults posted
• Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast ReconstructionTerminatedNCT01649505Not applicableResults posted
• Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaTerminatedNCT01620216Phase 2Results posted
• Therapy to Prevent Sexual Pain in Breast Cancer SurvivorsCompletedNCT01539317Phase 3Results posted
• Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue SarcomaCompletedNCT01532687Phase 2Results posted
• Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01498978Phase 2Results posted
• Dasatinib in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT01441882Phase 2Results posted
• Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone TherapyCompletedNCT01422408Phase 2Results posted
• Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell LymphomaTerminatedNCT01397591Phase 2Results posted
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelTerminatedNCT01253642Phase 2Results posted
• Sulforaphane in Treating Patients With Recurrent Prostate CancerCompletedNCT01228084Phase 2Results posted
• Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By ChemotherapyTerminatedNCT01031953Phase 1/2Results posted
• Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaTerminatedNCT01005914Phase 2Results posted
• DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain TumorsCompletedNCT00978562Early Phase 1Results posted
• Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast BiopsyCompletedNCT00843167Phase 2Results posted
• Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaCompletedNCT00764517Phase 2Results posted
• Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor TherapyTerminatedNCT00722072Phase 2Results posted
• Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaTerminatedNCT00691652Phase 1/2Results posted
• MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation TherapyCompletedNCT00660543Not applicableResults posted
• Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) InflammationTerminatedNCT00659334Phase 2Results posted
• Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedNCT00659126Phase 2Results posted
• Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)TerminatedNCT00642746Phase 2Results posted
• Docetaxel in Treating Patients With Relapsed Prostate CancerTerminatedNCT00482274Phase 2Results posted
• Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate CancerTerminatedNCT00459810Phase 2Results posted
• Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaTerminatedNCT00428077Phase 2Results posted
• Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00425386Phase 2Results posted
• Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CMLTerminatedNCT00416884Phase 2Results posted
• Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOXCompletedNCT00381862Phase 2Results posted

← OHSU Knight Cancer Institute overview and focus areas